24 Engineering "South Dakota School of Mines and Technology" research jobs at City of Hope in america
-
Fellowship within the laboratory of Dr Ed Boas, at the Beckman Research Institute of City of Hope. For more information on his research please visit here . We are looking for a biomedical engineer, materials
-
transduction, ELISA, CART production, CRISPR/Cas9 technology · In vivo skills: o Routes of drug administration: oral gavage, intraperitoneal, retro-orbital, subcutaneous, or tail vein injections o
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology
-
. For more information on Dr. Schones’ research please visit here . · PhD or M.D. in biology, computer science, biomedical engineering, physics or other related discipline. · Excellent
-
are seeking a fast-paced academic research environment. Our lab in the Department of Immuno-Oncology focuses on engineering tumor-colonizing bacteria to target components of the tumor microenvironment
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
and identification of HLA-restricted epitopes derived from them As a successful candidate, you will: · Work with both genetically engineered mouse models, patient-derived AML xenograft models